Researchers call for more flexible editorial conduct rather than abruptly adopting only the new MASLD nomenclature

作者：Amedeo Lonardo, Fernando Bril, Stephen H. Caldwell, Mohammed Eslam, Jian‐Gao Fan, Robert G. Gish, Henning Grønbæk, Sanal Madhusudana Girija, Norbert Stefan, Ayako Suzuki, Giovanni Targher, Herbert Tilg, Ming‐Lung Yu, Ming‐Hua Zheng, Jacob George · 发表于：Journal of Hepatology · 年份：2024 · DOI：10.1016/j.jhep.2024.01.012 · 被引用次数：34 · 研究领域：Liver Disease Diagnosis and Treatment、Alcohol Consumption and Health Effects、Hepatitis C virus research

Since many of us participated in the multi-society Delphi consensus statement on fatty liver disease nomenclature,1 we were interested in a recent article by Younossi and colleagues investigating potential stigma among patients with non-alcoholic fatty liver disease (NAFLD) and among healthcare providers.2 The authors concluded that the perception of NAFLD stigma varied among patients, providers, geographic locations, and sub-specialties.2 Of particular interest, only 8% of patients and 38% of doctors perceived stigma with use of the term.